L & S Advisors Inc Cyto Dyn Inc. Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$0.98 - $1.86 $98 - $186	-100 Reduced 0.2%	50,500 $50,000
Q3 2020 Nov 13, 2020	SELL	$2.92 - $6.48 $292 - $648	-100 Reduced 0.2%	50,600 $148,000
Q2 2020 Aug 13, 2020	BUY	$2.25 - $8.77 $450 - $1,754	200 Added 0.4%	50,700 $288,000
Q1 2020 May 13, 2020	BUY	$0.85 - $2.67 $29,665 - $93,183	34,900 Added 223.72%	50,500 $135,000
Q4 2019 Feb 13, 2020	BUY	$0.28 - $1.0 $4,368 - $15,600	15,600 New	15,600 $16,000

275K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $211M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.